Download Full Text (427 KB)


  • Proton Therapy Trials May Provide More Options for Patients with Non-Small Cell Lung Cancer: Proton therapy offers the potential to deliver a higher radiation dose to lung tumors and a lower dose to healthy tissues than does standard radiation therapy. However, the effectiveness of proton therapy has not yet been documented in clinical trials for patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer. Two ongoing trials of proton therapy aim to demonstrate its effectiveness and may change the standard of care for NSCLC.
  • Innovative "Basket" Trial Shows Promise of BRAF Inhibition in Various Cancers: A groundbreaking clinical trial is demonstrating the promise of BRAF inhibition in multiple types of cancer and helping change the way researchers test treatments for cancers with actionable genetic aberrations.
  • Reducing the Likelihood of Second Primary Cancers in Cancer Survivors: Cancer survivors are at risk of not only cancer recurrence but also a second primary cancer. Their risk of a second cancer typically higher than the risk of a first cancer in the general population, but an individual survivor's risk varies by the type of initial cancer and other factors. To help cancer survivors manage the risk, the clinical services at The University of Texas MD Anderson Cancer Center include risk reduction and screening for second primary cancers.
  • HOUSE CALL: Types of Radiation Therapy and How They Are Used- Various techniques are used to treat cancer with radiation
  • USEFULRESOURCES: Breast Cancer Survivorship Course.

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Liao, Zhongxing; Nguyen, Quynh-Nhu; Subbiah, Vivek; Bevers, Therese; Proton Therapy; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Vemurafenib; Proto-Oncogene Proteins B-raf; Erdheim-Chester Disease; Histiocytosis, Non-Langerhans-Cell; Cancer Survivors; Radiotherapy; Breast Neoplasms.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 61, Number 06, June 2016